Skip to main content
Search form
Search
Medicines for Malaria Venture
Developing antimalarials to save lives
Research & Development
MMV-supported projects
R&D areas of work
Next-generation medicines
Science of eradication
Products for vulnerable populations
Working with regulators
Information for scientists
Call for proposals
TPPs & TCPs
Learning resources for discovery scientists
Project of the year award
Computational chemistry
Global health compound design webinars
R&D challenges
Access
Products & projects
Areas of work
Supporting introduction
Enhancing reach
Informing R&D
Gathering market intelligence
Product maps
Tool Kits
Injectable Artesunate tool kit
Artesunate rectal capsules tool kit
Seasonal Malaria Chemoprevention tool kit
The road to health impact
Access challenges
Partnering
Our partner network
The PDP model
Socially responsible agreements
Our clinical centre partners
Our donors
Current donors
Past donors
Donate to MMV
Our impact
Achievements
Real life stories
About us
What we do
An overview of our work
Our strategic focus
Our history
People & governance
Staff bios
Staff map
Staff interviews
Board of Directors
MMV North America Board
Expert Scientific Advisory Committee
Access & Product Management Advisory Committee
Global Safety Board
Work with us
Jobs
RFPs/RFIs
MMV's internship programme
Policies
Diversity at MMV
Funding and expenditure
FAQs
Contact us
Malaria & medicines
Definitions and symptoms
Five species
Parasite lifecycle
Malaria facts & figures
Malaria treatment
History of antimalarials
Optimizing artemisinin production
Malaria online course
Newsroom
News & Press Releases
Films
Infographics
Interviews
Image slideshows
Publications
Audio
Events
MMV Open
Malaria
Libre
About Malaria
Libre
Participate in Malaria
Libre
Malaria
Libre
data repository
COVID Box
About the COVID Box
Request the COVID box
Supporting information
COVID Box terms and conditions
Pandemic Response Box
About the Pandemic Response Box
Request the Pandemic Response Box
Supporting information
Terms & conditions
Pathogen Box
About the Pathogen Box
Exploiting the Pathogen Box
Pathogen Box research
Supporting information
Terms & conditions
Malaria Box
About the Malaria Box
Malaria Box Research
Supporting information
Terms & conditions
Map of box orders
Follow-up guidelines
Open Source Drug Discovery
MMV Open Team
Contact us
Home
Newsroom
News & Press Releases
News & Press Releases
Filter
Category
All
News story
Press release
Topic
Access & product management
Donors
General
Open source
Partner
R&D
Search Terms
416 found
MMV awards Project of the Year 2019 to Novartis for the discovery of INE963
13 Jul 2020
MMV launches Malaria
Libre
, a new open source drug discovery programme
07 Jul 2020
ESAC member Sir Simon Campbell inducted into the RSC-BMCS Hall of Fame
30 Jun 2020
MMV deeply saddened by the loss of Dr Ricardo Thompson
26 Jun 2020
MMV’s Dr James Duffy appointed to RSC Lectureship
19 Jun 2020
MMV launches the COVID Box to stimulate new drug research
10 Jun 2020
MMV submits statement to 73rd World Health Assembly
19 May 2020
This World Malaria Day MMV supports Swiss Malaria Group's call for urgent action
25 Apr 2020
Thailand becomes first malaria-endemic country in Asia-Pacific to approve tafenoquine for radical cure of
P. vivax
malaria
24 Apr 2020
In support of the COVID-19 response
31 Mar 2020
MMV and LSTM collaborate to fill data gap on use of antimalarials during pregnancy
08 Mar 2020
International research partnership and EDCTP to invest €44m in next-generation antimalarials to combat drug-resistant malaria in Africa
03 Mar 2020
Malaria continues to strike pregnant women and children hardest and new tools are critical, according to WHO’s latest report
05 Dec 2019
Research for new drugs against neglected diseases and malaria in Brazil to receive funding boost totaling BRL 43.5 million
27 Nov 2019
MMV presents Lifetime Achievement Awards to three longstanding collaborators
25 Nov 2019
Country leaders pledge to boost malaria innovation and access to new and existing antimalarials
11 Nov 2019
Brazil becomes first malaria-endemic country to approve single-dose tafenoquine (Kozenis) for radical cure of
P. vivax
malaria
30 Oct 2019
MMV and PATH strengthen ties with APLMA in the fight against relapsing malaria
22 Oct 2019
WHO issues information note about Pyramax® (artesunate-pyronaridine) for uncomplicated malaria
09 Oct 2019
MMV contributes to the fight against schistosomiasis
30 Sep 2019
Via Grand Challenges Africa, MMV supports eight African drug discovery scientists
23 Sep 2019
Two reports on malaria eradication underline need for new tools and interventions
09 Sep 2019
MMV awards its Project of the Year 2018 to University of Dundee researchers
10 Jul 2019
MMV launches new
P. vivax
malaria information hub
26 Jun 2019
Life-saving malaria project in Zambia to expand
25 Apr 2019
Prof Jonathan Vennerstrom receives prestigious ACS Award for Creative Invention
24 Apr 2019
MMV participates in Swiss World Malaria Day event
24 Apr 2019
PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria
23 Apr 2019
Europe-Africa partnership spearheads development of next-generation antimalarial drug
15 Apr 2019
MMV and DND
i
make 400 compounds available to stimulate research into new drugs for pandemic diseases
29 Jan 2019
Two positive phase III studies of tafenoquine for the radical cure of
Plasmodium vivax
malaria published in The New England Journal of Medicine
16 Jan 2019
Professor Michael Ferguson receives Knighthood in New Year’s Honours List
14 Jan 2019
2018 - A triumph of partnerships
19 Dec 2018
Open source effort identifies hundreds of compounds that could protect vulnerable populations from malaria
07 Dec 2018
Access to Medicines Index highlights role of collaboration in stimulating R&D
21 Nov 2018
World Malaria Report highlights importance of country-led efforts to defeat malaria in highest burden countries
19 Nov 2018
Fosun Pharma’s medicine to protect pregnant women from malaria first to be approved by WHO
19 Nov 2018
Professor James McCarthy elected Fellow of Australian Academy of Health and Medical Sciences
31 Oct 2018
Ray Chambers appointed WHO Ambassador for Global Strategy
31 Oct 2018
Single-dose tafenoquine for radical cure of
P. vivax
malaria submitted for regulatory approval in Brazil
21 Sep 2018
Kozenis (tafenoquine) approved by the Australian Therapeutic Goods Administration for the radical cure of
P. vivax
malaria
21 Sep 2018
Severe malaria case fatality reduced by 96% in pilot project in Zambia led by Transaid, MMV and partners
28 Aug 2018
US FDA approves
Krintafel
(tafenoquine) for the radical cure of
P. vivax
malaria
20 Jul 2018
US FDA Advisory Committee endorses the effectiveness and safety of single-dose tafenoquine for the radical cure of
P. vivax
malaria
12 Jul 2018
MMV Project of the Year 2017 awarded to Sanofi
10 Jul 2018
Strides Shasun’s rectal artesunate product receives WHO prequalification
21 Jun 2018
MMV deeply saddened by the loss of Prof. Ogobara Doumbo
11 Jun 2018
Australia renews commitment to MMV and R&D for malaria
08 Jun 2018
MMV partner Kelly Chibale in Fortune Greatest Leaders list 2018
30 Apr 2018
MMV’s contributions to malaria commended at MIM conference
27 Apr 2018
Major study confirms tolerability and high efficacy of 4 gold-standard malaria medicines, when used for repeated treatment over a 2 year period
29 Mar 2018
WHO provides first-ever approval for rectal artesunate product for severe malaria
27 Feb 2018
MMV welcomes Philip Welkhoff, new Malaria Program Director, BMGF
14 Feb 2018
MMV and DNDi deliver joint statement at WHO Executive Board
27 Jan 2018
MMV end-of-year review 2017
02 Jan 2018
WHO issues information note on correct use of rectal artesunate for severe malaria
18 Dec 2017
Unitaid awards MMV new supply side grant
08 Dec 2017
PLOS Medicine publishes New Malaria Eradication Road Map
01 Dec 2017
Two new MMV-supported research sites inaugurated in Ethiopia
30 Nov 2017
Two MMV partners receive international award
30 Nov 2017
Pages
1
2
3
4
5
6
7
next ›
last »
